HomeNewsTrendsEntertainmentYou'll have to wait longer for films like Sooryavanshi, till then enjoy smaller theatrical offerings

You'll have to wait longer for films like Sooryavanshi, till then enjoy smaller theatrical offerings

So far, it is only smaller ventures that have kept the Bollywood flag flying as big-names releases wait for theatres to allow larger audience.

January 17, 2021 / 13:53 IST
Story continues below Advertisement

Tamil superstar Vijay’s Master is doing well at the box office but it will be sometime before big Bollywood films find their way into theatres. Producers of films like Akshay Kumar’s Sooryavanshi, Ranveer Singh’s 83 and Salman Khan’s Radhe are willing to wait for cinema halls to start operating at 100 percent capacity.

Producers of big Bollywood films are ready to wait a little longer until major states allow theatres to operate at full capacity, analyst Karan Taurani, Vice-President, Elara Capital, said. Even 75 percent capacity might work for such producers as average pan-India weekend occupancy was normally around 60 to 65 percent, he said.

Story continues below Advertisement

“Large producers won’t risk until they get 100 percent occupancy. They have waited for so long. So, they will wait a little longer,” Taurani said.

Taurani added that 50 percent occupancy was enough for medium budget films and they were already in talks for theatrical release. One such small venture ready to release in theatres is Richa Chadha’s Madam Chief Minister on January 22. Mere Desh ki Dharti starring Divyendu Sharma is also going to hit the screens the same day.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show